Design Therapeutics Inc (DSGN)
EBITDA
-$72.19M
TTM · Period ending: · USD
DSGN EBITDA
Latest reported-$72.19Mperiod ending
Latest reported-$72.19Mperiod ending
DSGN TTM EBITDA (-$8.33M → -$72.19M)
TTM EBITDA
High-resolution chart · PNG
DSGN ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -72,188,000 | |
| -69,093,000 | |
| -69,170,000 | |
| -66,831,000 | |
| -62,875,000 | |
| -55,586,000 | |
| -48,992,000 | |
| -47,194,000 | |
| -49,960,000 | |
| -58,122,000 | |
| -66,325,000 | |
| -71,837,000 | |
| -73,781,000 | |
| -68,884,000 | |
| -62,902,000 | |
| -56,669,000 | |
| -50,360,000 | |
| -43,077,000 | |
| -35,570,000 | |
| -28,444,000 | |
| -19,539,000 | |
| -13,378,000 | |
| -8,325,000 |